Table of Content

1 Non-Benzodiazepines Market Overview
1.1 Product Overview and Scope of Non-Benzodiazepines
1.2 Non-Benzodiazepines Segment by Type
1.2.1 Global Non-Benzodiazepines Market Value Comparison by Type (2024-2034)
1.2.2 Dexmedetomidine
1.2.3 Zolpidem
1.2.4 Eszopiclone
1.2.5 Zopiclone
1.2.6 other
1.3 Non-Benzodiazepines Segment by Application
1.3.1 Global Non-Benzodiazepines Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Non-Benzodiazepines Market Size Estimates and Forecasts
1.4.1 Global Non-Benzodiazepines Revenue 2024-2034
1.4.2 Global Non-Benzodiazepines Sales 2024-2034
1.4.3 Global Non-Benzodiazepines Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Non-Benzodiazepines Market Competition by Manufacturers
2.1 Global Non-Benzodiazepines Sales Market Share by Manufacturers (2024-2024)
2.2 Global Non-Benzodiazepines Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Non-Benzodiazepines Average Price by Manufacturers (2024-2024)
2.4 Global Non-Benzodiazepines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Non-Benzodiazepines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Benzodiazepines, Product Type & Application
2.7 Non-Benzodiazepines Market Competitive Situation and Trends
2.7.1 Non-Benzodiazepines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Benzodiazepines Players Market Share by Revenue
2.7.3 Global Non-Benzodiazepines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Benzodiazepines Retrospective Market Scenario by Region
3.1 Global Non-Benzodiazepines Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Non-Benzodiazepines Global Non-Benzodiazepines Sales by Region: 2024-2034
3.2.1 Global Non-Benzodiazepines Sales by Region: 2024-2024
3.2.2 Global Non-Benzodiazepines Sales by Region: 2024-2034
3.3 Global Non-Benzodiazepines Global Non-Benzodiazepines Revenue by Region: 2024-2034
3.3.1 Global Non-Benzodiazepines Revenue by Region: 2024-2024
3.3.2 Global Non-Benzodiazepines Revenue by Region: 2024-2034
3.4 North America Non-Benzodiazepines Market Facts & Figures by Country
3.4.1 North America Non-Benzodiazepines Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Non-Benzodiazepines Sales by Country (2024-2034)
3.4.3 North America Non-Benzodiazepines Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Benzodiazepines Market Facts & Figures by Country
3.5.1 Europe Non-Benzodiazepines Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Non-Benzodiazepines Sales by Country (2024-2034)
3.5.3 Europe Non-Benzodiazepines Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Benzodiazepines Market Facts & Figures by Country
3.6.1 Asia Pacific Non-Benzodiazepines Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Non-Benzodiazepines Sales by Country (2024-2034)
3.6.3 Asia Pacific Non-Benzodiazepines Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Benzodiazepines Market Facts & Figures by Country
3.7.1 Latin America Non-Benzodiazepines Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Non-Benzodiazepines Sales by Country (2024-2034)
3.7.3 Latin America Non-Benzodiazepines Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Non-Benzodiazepines Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Benzodiazepines Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Non-Benzodiazepines Sales by Country (2024-2034)
3.8.3 Middle East and Africa Non-Benzodiazepines Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Benzodiazepines Sales by Type (2024-2034)
4.1.1 Global Non-Benzodiazepines Sales by Type (2024-2024)
4.1.2 Global Non-Benzodiazepines Sales by Type (2024-2034)
4.1.3 Global Non-Benzodiazepines Sales Market Share by Type (2024-2034)
4.2 Global Non-Benzodiazepines Revenue by Type (2024-2034)
4.2.1 Global Non-Benzodiazepines Revenue by Type (2024-2024)
4.2.2 Global Non-Benzodiazepines Revenue by Type (2024-2034)
4.2.3 Global Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
4.3 Global Non-Benzodiazepines Price by Type (2024-2034)
5 Segment by Application
5.1 Global Non-Benzodiazepines Sales by Application (2024-2034)
5.1.1 Global Non-Benzodiazepines Sales by Application (2024-2024)
5.1.2 Global Non-Benzodiazepines Sales by Application (2024-2034)
5.1.3 Global Non-Benzodiazepines Sales Market Share by Application (2024-2034)
5.2 Global Non-Benzodiazepines Revenue by Application (2024-2034)
5.2.1 Global Non-Benzodiazepines Revenue by Application (2024-2024)
5.2.2 Global Non-Benzodiazepines Revenue by Application (2024-2034)
5.2.3 Global Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
5.3 Global Non-Benzodiazepines Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Pfizer Non-Benzodiazepines Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Corporation Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.2.4 Teva Pharmaceuticals Non-Benzodiazepines Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Torrent Pharma
6.3.1 Torrent Pharma Corporation Information
6.3.2 Torrent Pharma Description and Business Overview
6.3.3 Torrent Pharma Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Torrent Pharma Non-Benzodiazepines Product Portfolio
6.3.5 Torrent Pharma Recent Developments/Updates
6.4 Accord Healthcare
6.4.1 Accord Healthcare Corporation Information
6.4.2 Accord Healthcare Description and Business Overview
6.4.3 Accord Healthcare Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Accord Healthcare Non-Benzodiazepines Product Portfolio
6.4.5 Accord Healthcare Recent Developments/Updates
6.5 Akorn
6.5.1 Akorn Corporation Information
6.5.2 Akorn Description and Business Overview
6.5.3 Akorn Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Akorn Non-Benzodiazepines Product Portfolio
6.5.5 Akorn Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Apotex Non-Benzodiazepines Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Fresenius Kabi Non-Benzodiazepines Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Corporation Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Hikma Non-Benzodiazepines Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Mylan Non-Benzodiazepines Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Par Pharmaceuticals
6.10.1 Par Pharmaceuticals Corporation Information
6.10.2 Par Pharmaceuticals Description and Business Overview
6.10.3 Par Pharmaceuticals Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Par Pharmaceuticals Non-Benzodiazepines Product Portfolio
6.10.5 Par Pharmaceuticals Recent Developments/Updates
6.11 Sandoz
6.11.1 Sandoz Corporation Information
6.11.2 Sandoz Non-Benzodiazepines Description and Business Overview
6.11.3 Sandoz Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.11.4 Sandoz Non-Benzodiazepines Product Portfolio
6.11.5 Sandoz Recent Developments/Updates
6.12 Sun Pharma
6.12.1 Sun Pharma Corporation Information
6.12.2 Sun Pharma Non-Benzodiazepines Description and Business Overview
6.12.3 Sun Pharma Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Sun Pharma Non-Benzodiazepines Product Portfolio
6.12.5 Sun Pharma Recent Developments/Updates
6.13 WG Critical Care
6.13.1 WG Critical Care Corporation Information
6.13.2 WG Critical Care Non-Benzodiazepines Description and Business Overview
6.13.3 WG Critical Care Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.13.4 WG Critical Care Non-Benzodiazepines Product Portfolio
6.13.5 WG Critical Care Recent Developments/Updates
6.14 Athenex
6.14.1 Athenex Corporation Information
6.14.2 Athenex Non-Benzodiazepines Description and Business Overview
6.14.3 Athenex Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.14.4 Athenex Non-Benzodiazepines Product Portfolio
6.14.5 Athenex Recent Developments/Updates
6.15 Chenxin Pharmaceutical
6.15.1 Chenxin Pharmaceutical Corporation Information
6.15.2 Chenxin Pharmaceutical Non-Benzodiazepines Description and Business Overview
6.15.3 Chenxin Pharmaceutical Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Chenxin Pharmaceutical Non-Benzodiazepines Product Portfolio
6.15.5 Chenxin Pharmaceutical Recent Developments/Updates
6.16 Huatai Chenguang Pharmaceutical
6.16.1 Huatai Chenguang Pharmaceutical Corporation Information
6.16.2 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Description and Business Overview
6.16.3 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Sales, Revenue and Gross Margin (2024-2024)
6.16.4 Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product Portfolio
6.16.5 Huatai Chenguang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Benzodiazepines Industry Chain Analysis
7.2 Non-Benzodiazepines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Benzodiazepines Production Mode & Process
7.4 Non-Benzodiazepines Sales and Marketing
7.4.1 Non-Benzodiazepines Sales Channels
7.4.2 Non-Benzodiazepines Distributors
7.5 Non-Benzodiazepines Customers
8 Non-Benzodiazepines Market Dynamics
8.1 Non-Benzodiazepines Industry Trends
8.2 Non-Benzodiazepines Market Drivers
8.3 Non-Benzodiazepines Market Challenges
8.4 Non-Benzodiazepines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Non-Benzodiazepines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Non-Benzodiazepines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Non-Benzodiazepines Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-Benzodiazepines Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Non-Benzodiazepines Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Non-Benzodiazepines Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Non-Benzodiazepines Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Non-Benzodiazepines Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Non-Benzodiazepines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Non-Benzodiazepines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-Benzodiazepines, Product Type & Application
Table 12. Global Key Manufacturers of Non-Benzodiazepines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-Benzodiazepines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Benzodiazepines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-Benzodiazepines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Non-Benzodiazepines Sales by Region (2024-2024) & (K Units)
Table 18. Global Non-Benzodiazepines Sales Market Share by Region (2024-2024)
Table 19. Global Non-Benzodiazepines Sales by Region (2024-2034) & (K Units)
Table 20. Global Non-Benzodiazepines Sales Market Share by Region (2024-2034)
Table 21. Global Non-Benzodiazepines Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Non-Benzodiazepines Revenue Market Share by Region (2024-2024)
Table 23. Global Non-Benzodiazepines Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Non-Benzodiazepines Revenue Market Share by Region (2024-2034)
Table 25. North America Non-Benzodiazepines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 27. North America Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 28. North America Non-Benzodiazepines Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Non-Benzodiazepines Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Non-Benzodiazepines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 32. Europe Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 33. Europe Non-Benzodiazepines Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Non-Benzodiazepines Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Non-Benzodiazepines Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Non-Benzodiazepines Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Non-Benzodiazepines Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Non-Benzodiazepines Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Non-Benzodiazepines Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Non-Benzodiazepines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Non-Benzodiazepines Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Non-Benzodiazepines Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Non-Benzodiazepines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Non-Benzodiazepines Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Non-Benzodiazepines Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Non-Benzodiazepines Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Non-Benzodiazepines Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Non-Benzodiazepines Sales (K Units) by Type (2024-2024)
Table 51. Global Non-Benzodiazepines Sales (K Units) by Type (2024-2034)
Table 52. Global Non-Benzodiazepines Sales Market Share by Type (2024-2024)
Table 53. Global Non-Benzodiazepines Sales Market Share by Type (2024-2034)
Table 54. Global Non-Benzodiazepines Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Non-Benzodiazepines Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Non-Benzodiazepines Revenue Market Share by Type (2024-2024)
Table 57. Global Non-Benzodiazepines Revenue Market Share by Type (2024-2034)
Table 58. Global Non-Benzodiazepines Price (US$/Unit) by Type (2024-2024)
Table 59. Global Non-Benzodiazepines Price (US$/Unit) by Type (2024-2034)
Table 60. Global Non-Benzodiazepines Sales (K Units) by Application (2024-2024)
Table 61. Global Non-Benzodiazepines Sales (K Units) by Application (2024-2034)
Table 62. Global Non-Benzodiazepines Sales Market Share by Application (2024-2024)
Table 63. Global Non-Benzodiazepines Sales Market Share by Application (2024-2034)
Table 64. Global Non-Benzodiazepines Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Non-Benzodiazepines Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Non-Benzodiazepines Revenue Market Share by Application (2024-2024)
Table 67. Global Non-Benzodiazepines Revenue Market Share by Application (2024-2034)
Table 68. Global Non-Benzodiazepines Price (US$/Unit) by Application (2024-2024)
Table 69. Global Non-Benzodiazepines Price (US$/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. Pfizer Non-Benzodiazepines Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Teva Pharmaceuticals Corporation Information
Table 76. Teva Pharmaceuticals Description and Business Overview
Table 77. Teva Pharmaceuticals Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. Teva Pharmaceuticals Non-Benzodiazepines Product
Table 79. Teva Pharmaceuticals Recent Developments/Updates
Table 80. Torrent Pharma Corporation Information
Table 81. Torrent Pharma Description and Business Overview
Table 82. Torrent Pharma Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Torrent Pharma Non-Benzodiazepines Product
Table 84. Torrent Pharma Recent Developments/Updates
Table 85. Accord Healthcare Corporation Information
Table 86. Accord Healthcare Description and Business Overview
Table 87. Accord Healthcare Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Accord Healthcare Non-Benzodiazepines Product
Table 89. Accord Healthcare Recent Developments/Updates
Table 90. Akorn Corporation Information
Table 91. Akorn Description and Business Overview
Table 92. Akorn Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Akorn Non-Benzodiazepines Product
Table 94. Akorn Recent Developments/Updates
Table 95. Apotex Corporation Information
Table 96. Apotex Description and Business Overview
Table 97. Apotex Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Apotex Non-Benzodiazepines Product
Table 99. Apotex Recent Developments/Updates
Table 100. Fresenius Kabi Corporation Information
Table 101. Fresenius Kabi Description and Business Overview
Table 102. Fresenius Kabi Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Fresenius Kabi Non-Benzodiazepines Product
Table 104. Fresenius Kabi Recent Developments/Updates
Table 105. Hikma Corporation Information
Table 106. Hikma Description and Business Overview
Table 107. Hikma Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Hikma Non-Benzodiazepines Product
Table 109. Hikma Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Mylan Non-Benzodiazepines Product
Table 114. Mylan Recent Developments/Updates
Table 115. Par Pharmaceuticals Corporation Information
Table 116. Par Pharmaceuticals Description and Business Overview
Table 117. Par Pharmaceuticals Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Par Pharmaceuticals Non-Benzodiazepines Product
Table 119. Par Pharmaceuticals Recent Developments/Updates
Table 120. Sandoz Corporation Information
Table 121. Sandoz Description and Business Overview
Table 122. Sandoz Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. Sandoz Non-Benzodiazepines Product
Table 124. Sandoz Recent Developments/Updates
Table 125. Sun Pharma Corporation Information
Table 126. Sun Pharma Description and Business Overview
Table 127. Sun Pharma Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Sun Pharma Non-Benzodiazepines Product
Table 129. Sun Pharma Recent Developments/Updates
Table 130. WG Critical Care Corporation Information
Table 131. WG Critical Care Description and Business Overview
Table 132. WG Critical Care Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. WG Critical Care Non-Benzodiazepines Product
Table 134. WG Critical Care Recent Developments/Updates
Table 135. Athenex Corporation Information
Table 136. Athenex Description and Business Overview
Table 137. Athenex Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. Athenex Non-Benzodiazepines Product
Table 139. Athenex Recent Developments/Updates
Table 140. Chenxin Pharmaceutical Corporation Information
Table 141. Chenxin Pharmaceutical Description and Business Overview
Table 142. Chenxin Pharmaceutical Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Chenxin Pharmaceutical Non-Benzodiazepines Product
Table 144. Chenxin Pharmaceutical Recent Developments/Updates
Table 145. Huatai Chenguang Pharmaceutical Corporation Information
Table 146. Huatai Chenguang Pharmaceutical Description and Business Overview
Table 147. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. Huatai Chenguang Pharmaceutical Non-Benzodiazepines Product
Table 149. Huatai Chenguang Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Non-Benzodiazepines Distributors List
Table 153. Non-Benzodiazepines Customers List
Table 154. Non-Benzodiazepines Market Trends
Table 155. Non-Benzodiazepines Market Drivers
Table 156. Non-Benzodiazepines Market Challenges
Table 157. Non-Benzodiazepines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-Benzodiazepines
Figure 2. Global Non-Benzodiazepines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Non-Benzodiazepines Market Share by Type in 2022 & 2034
Figure 4. Dexmedetomidine Product Picture
Figure 5. Zolpidem Product Picture
Figure 6. Eszopiclone Product Picture
Figure 7. Zopiclone Product Picture
Figure 8. other Product Picture
Figure 9. Global Non-Benzodiazepines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Non-Benzodiazepines Market Share by Application in 2022 & 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Global Non-Benzodiazepines Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Non-Benzodiazepines Market Size (2024-2034) & (US$ Million)
Figure 16. Global Non-Benzodiazepines Sales (2024-2034) & (K Units)
Figure 17. Global Non-Benzodiazepines Average Price (US$/Unit) & (2024-2034)
Figure 18. Non-Benzodiazepines Report Years Considered
Figure 19. Non-Benzodiazepines Sales Share by Manufacturers in 2022
Figure 20. Global Non-Benzodiazepines Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Non-Benzodiazepines Players: Market Share by Revenue in 2022
Figure 22. Non-Benzodiazepines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global Non-Benzodiazepines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America Non-Benzodiazepines Sales Market Share by Country (2024-2034)
Figure 25. North America Non-Benzodiazepines Revenue Market Share by Country (2024-2034)
Figure 26. United States Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe Non-Benzodiazepines Sales Market Share by Country (2024-2034)
Figure 29. Europe Non-Benzodiazepines Revenue Market Share by Country (2024-2034)
Figure 30. Germany Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific Non-Benzodiazepines Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific Non-Benzodiazepines Revenue Market Share by Region (2024-2034)
Figure 37. China Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America Non-Benzodiazepines Sales Market Share by Country (2024-2034)
Figure 45. Latin America Non-Benzodiazepines Revenue Market Share by Country (2024-2034)
Figure 46. Mexico Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Colombia Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Non-Benzodiazepines Sales Market Share by Country (2024-2034)
Figure 51. Middle East & Africa Non-Benzodiazepines Revenue Market Share by Country (2024-2034)
Figure 52. Turkey Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. UAE Non-Benzodiazepines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Non-Benzodiazepines by Type (2024-2034)
Figure 56. Global Revenue Market Share of Non-Benzodiazepines by Type (2024-2034)
Figure 57. Global Non-Benzodiazepines Price (US$/Unit) by Type (2024-2034)
Figure 58. Global Sales Market Share of Non-Benzodiazepines by Application (2024-2034)
Figure 59. Global Revenue Market Share of Non-Benzodiazepines by Application (2024-2034)
Figure 60. Global Non-Benzodiazepines Price (US$/Unit) by Application (2024-2034)
Figure 61. Non-Benzodiazepines Value Chain
Figure 62. Non-Benzodiazepines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed